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Neisseria meningitidis serogroup B is a pathogen that can infect diverse sites within the human
host. According to the N. meningitidis genomic information and experimental observations,
glucose can be completely catabolized through the Entner–Doudoroff pathway and the pentose
phosphate pathway. The Embden–Meyerhof–Parnas pathway is not functional, because the gene
for phosphofructokinase (PFK) is not present. The phylogenetic distribution of PFK indicates that
in most obligate aerobic organisms, PFK is lacking. We conclude that this is because of the
limited contribution of PFK to the energy supply in aerobically grown organisms in comparison
with the energy generated through oxidative phosphorylation. Under anaerobic or microaerobic
conditions, the available energy is limiting, and PFK provides an advantage, which explains the
presence of PFK in many (facultatively) anaerobic organisms. In accordance with this, in silico flux
balance analysis predicted an increase of biomass yield as a result of PFK expression. However,
analysis of a genetically engineered N. meningitidis strain that expressed a heterologous PFK
showed that the yield of biomass on substrate decreased in comparison with a pfkA-deficient
control strain, which was associated mainly with an increase in CO2 production, whereas
production of by-products was similar in the two strains. This might explain why the pfkA gene has
not been obtained by horizontal gene transfer, since it is initially unfavourable for biomass yield. No
large effects related to heterologous expression of pfkA were observed in the transcriptome.
Although our results suggest that introduction of PFK does not contribute to a more efficient strain
in terms of biomass yield, achievement of a robust, optimal metabolic network that enables a
higher growth rate or a higher biomass yield might be possible after adaptive evolution of the
strain, which remains to be investigated.
Abbreviations: dcw, dry cell weight; ED, Entner–Doudoroff; EMP, Embden–Meyerhof–Parnas; F6P, fructose 6-phosphate; FBA, flux balance analysis; FR,
fold ratio; HGT, horizontal gene transfer; LP, linear programming; MCS, Monte Carlo simulation; NVI, Netherlands Vaccine Institute; PEP,
phosphoenolpyruvate; PP, pentose phosphate, PTS system, phosphotransferase system.
3Present address: Ghent University, Department of Plant Systems Biology/Department of Biology, Technologiepark 927, 9052 Ghent, Belgium.
The microarray data discussed in this paper are available under GEO accession number GSE18951.
Three supplementary tables, showing the relationships in bacterial species between PFK (encoded by pfkA), the glucose-specific PTS transporter EIIBGlc
(encoded by ptsG) and glucokinase, GK (encoded by glk), are available with the online version of this paper. Additional data are also available with the
online version of this paper in the form of the Excel file Additional data.xls, which includes six worksheets. The first worksheet, named ‘model’, contains the
simplified metabolic model. The second worksheet, named ‘abbreviations’, contains a list of abbreviations of the metabolites. The third worksheet, named
‘flux distributions’, contains the calculated flux distributions of all experimental datasets. The fourth worksheet, named ‘phylogenetic profiling’, contains the
phylogenetic profile of 373 species, and is available as a separate PDF. The fifth worksheet, named ‘phylo reactions’, contains the relevant reactions list
and the amino acid sequences used for the phylogenetic profiling. The sixth worksheet, named ‘transcriptome’, contains the gene expression data.
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INTRODUCTION
The species Neisseria meningitidis (the meningococcus) is
only found in humans, colonizing mucosal surfaces of the
nasopharynx as a harmless commensal organism, and as
such is carried by at least 5–10% of the adult population
(Rosenstein et al., 2001; Stephens et al., 1983). Some strains
are able to cross the mucosa into the bloodstream, from
where they can cause the diseases meningitis and sep-
ticaemia. There are different pathogenic N. meningitidis
isolates, of which five serogroups (A, B, C, Y and W135) are
responsible for most disease. Conjugate polysaccharide
vaccines that offer protection against infection with
meningococcal serogroups A, C, Y and W-135 are effective
and have been widely used (Girard et al., 2006; Trotter &
Ramsay, 2007). However, a broadly protective vaccine
against infection by serogroup B N. meningitidis is not yet
available, although this serogroup contributes significantly
to the burden of meningococcal disease in many indus-
trialized countries, where both epidemic and endemic
serogroup B infections occur (Zimmer & Stephens, 2006).
At the Netherlands Vaccine Institute (NVI), a cross-
protective multivalent vaccine against serogroup B organ-
isms, including different subcapsular porin A (PorA)
proteins contained in outer membrane vesicles (OMVs), is
currently being developed. The vaccine development process
focuses on cultivation of the organism, extraction of OMVs
and subsequent purification of the PorA-containing OMVs
(Baart et al., 2007b). Knowledge of the primary metabolism
is essential for the development of a consistent cultivation
step in the vaccine production process. For this reason, anN.
meningitidis serogroup B genome-scale metabolic model has
been built and used to study primary metabolism (Baart et
al., 2007a, 2008). Earlier studies on glucose utilization in N.
meningitidis confirm the presence of enzymes related to the
glycolytic Embden–Meyerhof–Parnas (EMP) pathway, the
Entner–Doudoroff (ED) pathway and the pentose phos-
phate (PP) pathway (Holten, 1974, 1975; Jyssum et al., 1961;
Jyssum, 1962a, b, c) (Fig. 1). However, it has been found that
the EMP pathway does not contribute to pyruvate synthesis,
indicating that the EMP pathway is not functional. These
observations are in accordance with the N. meningitidis
serogroup B genome (Tettelin et al., 2000), in which a gene
encoding phosphofructokinase (PFK) is not present. In
order to improve the efficiency of the cultivation step in the
vaccine production process we extended N. meningitidis
metabolism with PFK. Furthermore, we used a comparative
genomics approach to establish which factors determine the
presence or absence of PFK in bacteria.
PFK (EC 2.7.1.11) is a key enzyme in glycolysis and is known
to be regulated by allosteric effectors. The regulation of
enzymes by allosteric effectors is a major mechanism of
metabolic control, since it couples the activity of an enzyme
to changes in the concentrations of metabolites produced by
reactions that are distant in the metabolic network. PFK
catalyses the irreversible phosphorylation of fructose 6-
phosphate (F6P) to fructose 1,6-bisphosphate (FBP) using
ATP, and is allosterically inhibited by phosphoenolpyruvate
(PEP) and activated by ADP (or GDP) when the energy
demand of the cell increases (Blangy et al., 1968). The ATP-
PFK described above (PFK-1) is broadly distributed in
Eukaryota and Bacteria, as indicated by homologous protein
sequences and biochemical evidence (Bapteste et al., 2003),
and is encoded by the pfkA gene. A second type of ATP-PFK
enzyme (PFK-2), found strictly in Escherichia coli and
encoded by the pfkB gene, has a minor activity (~10% of the
total) (Fraenkel, 1996) and is inhibited by ATP at low
concentrations of F6P (Guixe & Babul, 1985). The inorganic
pyrophosphate (PPi)-dependent PFK (PPi-PFK) catalyses
the same reaction using PPi in a reversible manner, and can
thus function in both glycolysis and gluconeogenesis. PPi-
PFK (EC 2.7.1.90) has a more limited distribution, but is
also found in eukaryotes and bacteria (Bapteste et al., 2003).
ATP-PFK and PPi-PFK share a common ancestry, but
phylogenies show a very complex evolutionary pattern
(Muller et al., 2001; Siebers et al., 1998). Some Archaea
contain a unique ADP-dependent PFK (ADP-PFK) that
appears to be phylogenetically distinct and instead belongs
to the glucokinase family of kinases (Ito et al., 2001; Verhees
et al., 2001). Bapteste et al. (2003) addressed the taxonomic
distribution of ATP- and PPi-dependent PFKs and con-
cluded that numerous horizontal gene transfer (HGT)
events and substitution of amino acids in the catalytic sites
appear to occur at a high rate. None of the above-mentioned
types of PFK are present in N. meningitidis. If it is assumed
that N. meningitidis once had a functional PFK and that
during the evolution of the species this activity was lost
(Bapteste et al., 2003), the question of why N. meningitidis
lost PFK activity remains. In particular, since glucose is
present within nasopharyngeal tissue (Exley et al., 2005), the
presence of PFK can yield one additional ATP per unit of
substrate consumed, which is the case for all substrates that
enter metabolism at a level above F6P.
It has been shown that Neisseria species preferentially take
up DNA from their own genus (Davidsen & Tonjum, 2006;
Elkins et al., 1991), and this process of DNA exchange by
HGT has been implicated in the evolution of argF (Zhou &
Spratt, 1992), alteration of penA resulting in penicillin
resistance (Spratt et al., 1992), pilin antigenic variation
(Seifert et al., 1988) and other genetic alterations. Since
none of the Neisseria species of which the complete genome
sequences are publicly available contain PFK homologues
(Bentley et al., 2007; Parkhill et al., 2000; Peng et al., 2008;
Tettelin et al., 2000; http://www.genome.ou.edu/gono_
new.html), HGT events within and between Neisseria
species can never result in PFK functionality. However,
DNA exchange between phylogenetically divergent species
is possible (Omelchenko et al., 2003), as shown by the
acquisition of sodC in N. meningitidis from Haemophilus
influenzae by HGT (Kroll et al., 1998). Since H. influenzae
contains a gene encoding pfkA, the possibility for N.
meningitidis to obtain this gene exists. Hence, the question
of why N. meningitidis did not acquire the pfkA gene from,
for instance, H. influenzae in order to enhance growth as in
E. coli remains unanswered. In order to establish what
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determines the presence or absence of PFK in a species we
used phylogenetic profiling and the literature as a starting
point. In addition, we engineered a recombinant N.
meningitidis strain to determine the influence of hetero-
logous expression of PFK on biomass yield and composi-
tion, and analysed the strain at the metabolic and
transcriptome level.
METHODS
Bacterial strains and growth conditions. Competent E. coli cells
(strain TOP10, Invitrogen) were used for cloning purposes.
Transformants of E. coli were grown on solid or liquid Luria–
Bertani medium (BD Biosciences) containing either 100 mg kanamy-
cin ml21 or 100 mg ampicillin ml21, and, when necessary, 1 mM
IPTG and X-Gal. N. meningitidis strain HB-1, a non-encapsulated,
non-piliated variant of the group B isolate H44/76 (Bos &
Tommassen, 2005), was used for genetic modification.
Untransformed N. meningitidis HB-1 cells were grown overnight on
GC medium base plates (BD Biosciences) supplemented with
IsoVitaleX (BD Biosciences) or in liquid meningococcal medium
(van der Ley et al., 1993), while HB-1 derivatives were grown on GC
medium base plates containing kanamycin (100 mg ml21). All
incubations were done in a CO2 incubator at 37 uC in a humid
atmosphere containing 5% CO2. The final N. meningitidis HB-1
mutants (HB-1+kanR and HB-1+kanR+pfkA) were used to
generate bacterial stock cultures using chemically defined medium
Fig. 1. Overview of N. meningitidis metabolism. The gene encoding PFK is not present in N. meningitidis. Abbreviations are
listed in the abbreviations worksheet of the Additional Data spreadsheet available with the supplementary data.
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(Baart et al., 2007a) to ensure starting material of consistent quality
for the chemostat cultures. After the addition of glycerol (20%, v/v,
final concentration), the stock cultures were stored at 2135 uC, and
when required, a 500 ml shake flask containing 150 ml medium was
inoculated with 10 ml stock culture that contained 0.5 g biomass l21.
After approximately 8 h of incubation at 35 uC with shaking at
200 r.p.m. in an aerobic humid atmosphere, the culture was used to
inoculate the bioreactor. Bacteria were grown on minimal chemically
defined medium (Baart et al., 2007a) in 3 l autoclavable ADI
bioreactors (Applikon), operated in chemostat mode, with a working
volume of 1.4 l. Temperature, pH, dissolved oxygen (DO) concen-
tration and stirrer speed were 37 uC, 7.0, 30% and 600 r.p.m.,
respectively. The total gas flow rate was kept constant at 1.0 l min21.
The oxygen concentration was controlled by changing the oxygen
fraction in the gas flow using headspace aeration only. The growth
rate was 0.13 h21. After at least four residence times, physiological
steady state was assumed based on online measurements (constant
DO signal, O2 and CO2 concentration in the off-gas) and offline
measurements (constant optical density, glucose concentration). In
steady state, four small samples were taken using a rapid sampling
procedure as described below, and a large 1.0 l sample was taken,
divided into portions and processed as described previously (Baart et
al., 2007a). All chemostats were run in duplicate.
Analytical procedures. Dry biomass concentration was determined
by fourfold measurements for each steady-state sample by centrifu-
gation (8000 g) of 50–200 ml culture broth in preweighed tubes
followed by drying (24 h, 80 uC). Before weighing, the tubes were
cooled in a desiccator for at least 1 h and dry cell weight (dcw) was
corrected for salts present in the medium. The O2 and CO2
concentrations in the exhaust gas from the chemostat cultures were
measured with a mass spectrometer (Prima White Box 600, Thermo
Electron). The volumetric oxygen transfer coefficient, kLa, in the
bioreactors was determined accurately at 37 uC using a steady-state
set-up similar to that used by Dorresteijn et al. (1994). Glucose,
lactate and ammonium in the culture supernatant were determined as
described previously (Baart et al., 2007a). Acetate, ethanol and other
possible metabolites present in the culture supernatant were
determined by 1H-NMR as described previously (Baart et al.,
2007a). The molecular and macromolecular composition of biomass
was determined experimentally as described previously (Baart et al.,
2007a, 2008), and was very important in mathematical modelling of
cellular metabolism (Lange & Heijnen, 2001). PFK activity was
measured enzymically in cell-free extracts using a coupling enzyme
assay (Fordyce et al., 1982). Briefly, cell-free extract was obtained by
applying five freeze/thaw cycles to the cells, which were resuspended
in MilliQ water, followed by centrifugation (8000 g, 30 min), to
remove insoluble cellular fragments, and sterilization of the lysate by
filtration (0.22 mm pore-size). To determine PFK activity, 50 ml cell-
free extract was added to 900 ml of a 55.56 mM Tris/HCl buffer
(pH 7.5) containing 5.56 mM MgCl2, 55.56 mM KCl, 1.39 mM ATP,
0.17 mM NADH, 1.8 U aldolase ml21, 8.89 U triose phosphate
isomerase ml21 and 2.27 U glycerol phosphate dehydrogenase ml21.
The reaction was started by adding 50 ml F6P solution (100 mM).
PFK activity was determined by measuring the decrease in A340 (as a
consequence of NADH oxidation) for 10 min. E. coli cell-free extract
was used as a positive control for PFK activity, whereas cell-free
extract of N. meningitidis HB-1+kanR was used as a negative control
(and blank).
Recombinant DNA techniques. Since E. coli plasmids are not able
to persist in N. meningitidis, and because no high-copy-number
plasmids exist for N. meningitidis, heterologous expression of a gene
can only be achieved by homologous recombination. To use this
strategy, the gene of interest has to be inserted into a vector between
DNA sequences homologous to the site at which the gene has to be
inserted into the genome. Besides being used for homologous
recombination, these homologous sequences must also contain a
DNA uptake sequence. A kanamycin resistance gene must be present
between the homologous regions to select for transformants after
transformation. The final plasmid constructed in this study that was
used for transformation of N. meningitidis strain HB-1 contained a
sequence homologous to a DNA sequence situated just downstream
of the rmpM gene, which encodes a class 4 outer-membrane protein.
This is the location of choice, because of constitutive expression of
genes from this site (van der Ley & van Alphen, 2001). Incorporation
of heterologous pfkA at this site leads to its expression by the rmpM
promoter. Although standard methods were used for DNA prepara-
tion, restriction enzyme analysis, cloning and sequencing (Sambrook
et al., 1989), the cloning procedure to obtain the pfkA+ phenotype
(HB-1+kanR+pfkA) and the HB-1+kanR control phenotype is
described briefly below.
PCR and sequencing. After identification of the location of the pfkA
gene in E. coli K-12 using the NCBI database, PCR was used to
amplify an E. coli DNA fragment containing pfkA with Taq
polymerase. Sci Ed Clone Manager 6 (Scientific & Educational
Software) was used to design the forward (59-CAAGAAGA-
CTTCCGGCAACA-39) and reverse oligonucleotide primers (59-
TGATAAGCGAAGCGCATCAG-39). Primers were synthesized by
Sigma-Genosys. The forward primer anneals 55 bp upstream of the
ATG start codon while the reverse primer anneals 79 bp downstream
of the TAA stop codon, which results in a pfkA-containing DNA
fragment of 1096 bp.
The primers were diluted to a concentration of 1 mmol ml21 and were
added to puReTag ready-to-go PCR beads (Amersham Biosciences)
prior to the addition of E. coli cells. Using six combinations of
mixtures containing various amounts of primers and E. coli cells, PCR
was carried out (GeneAmp PCR system 9600, Perkin Elmer) using the
following cycling conditions. Initial denaturation of the template
DNA at 94 uC for 5 min followed by 30 cycles of 94 uC for 15 min,
55 uC for 30 s and 72 uC for 1 min, and completed with 7 min at
72 uC and 4 uC until further processing. From each reaction mixture,
10 ml was added to 4 ml loading buffer (1 mM EDTA, 0.25%
bromophenol blue, 40% sucrose) and analysed on a 1% agarose gel
using 16 TBE buffer (Bio-Rad) at 100 V for 30 min, to check for
sufficient amplification of the DNA fragment. It was found that 10 ml
primers in combination with 1–2 ml E. coli cells gave the best results
(results not shown). The generated 1096 bp fragment was cloned into
the pCR 2.1-TOPO plasmid, using the TOPO TA cloning kit
(Invitrogen), according to the manufacturer’s protocol. The plasmids
were purified from the culture using a miniprep kit (Promega). After
digestion of the plasmid DNA (37 uC, 2 h) using HindIII and EcoRV,
samples were analysed for the presence of the pfkA gene by agarose gel
electrophoresis, and fragments were purified from the gel using the
Promega Gel and PCR Clean-Up system according to the manu-
facturer’s protocol. Fragments were checked by sequencing using the
ABI Prism DNA sequencing kit (Applied Biosystems) according to the
manufacturer’s protocol. In order to obtain reliable sequencing
results, a primer annealing at position 359 of the DNA fragment was
designed (59-GGCGGTGACGGTTCCTACAT-39) and sequencing
was performed on an ABI Prism 310 genetic analyser (Applied
Biosystems). Sequencing of eight pCR-TOPO-pfkA constructs
resulted in one usable construct (pTOPO-pfkA).
Constructs. A pCF-linker plasmid, containing the sites necessary for
DNA uptake and homologous recombination was available from
previous studies (van der Ley et al., 1995). Since a usable construct
has to contain a kanamycin resistance gene (kanR) next to the pfkA
gene and both genes have to be cloned in the BamHI site of the pCF-
linker plasmid, a construct was prepared containing both the
kanamycin resistance gene and pfkA. Briefly, the procedure was as
follows. First, the pTOPO-pfkA plasmid and a pBluescript vector,
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which contains an ampicillin resistance gene (Stratagene), were
digested by HindIII and EcoRV. Digestion of the pTOPO-pfkA by
these enzymes resulted in an 1173 bp fragment containing pfkA which
was purified as described above. Second, the purified fragment was
ligated into the pBluescript vector (pBlue-pfkA) and transformation
was done in medium containing ampicillin. Third, a kanamycin
resistance gene was obtained from an available pUC4K vector (van
der Ley et al., 1995) by digestion with PstI and subsequent
purification. The kanamycin resistance gene was ligated into the
pBlue-pfkA vector (pBlue-PK) and transformant selection was done
in medium containing kanamycin. After purification of the resulting
plasmid DNA, the orientation of the kanamycin resistance gene was
checked by XhoI digestion. Plasmids containing the correct
orientation were selected, yielding the required pfkA–kanR fragment.
After ligation of the pfkA–kanR fragment into the BamHI site of pCF-
linker, transformation of competent E. coli cells was carried out and
transformant selection was done in medium containing kanamycin,
yielding the final pCF-linker-pfkA-kanR plasmid (pCF-PK). For
correct expression by the rmpM promoter, the orientation of the
fragment was checked by NdeI and XbaI digestion. Plasmids
containing the fragment in the correct orientation were selected
and used for transformation of N. meningitidis HB-1. After
transformation, a PCR was done with the primers for pfkA, which
confirmed the presence of the inserted DNA fragment. The control
strain was created by cutting both pCF-linker and pUC4K with
BamHI. After purification of the fragments, kanR was ligated into
pCF-linker, yielding the pCF-K plasmid. The orientation of kanR in
this construct was checked by digestion with XbaI and ClaI. This
construct was used for transformation of N. meningitidis HB-1.
Transformation. The plasmid-constructs (pCF-PK and pCF-K) were
cut using KpnI and the linear DNA was used for transformation.
Overnight-grown N. meningitidis strain HB-1 was scraped from the
gonococcal (GC) agar plate using a swab and resuspended in 10 ml
meningococcal medium containing 10 mM MgCl2. The suspension
was diluted fivefold in the same medium. A 2.5 ml volume of linear
construct DNA (1 mg ml21) was added to 2.5 ml of the diluted
suspension. After transformation (37 uC, 3 h), 250 ml suspension was
plated on GC agar plates containing kanamycin. Plates were stored
overnight in a CO2 incubator. Colonies obtained this way were picked
and plated again on kanamycin-containing GC plates to get rid of
untransformed cells, which remain alive but cannot grow in the
presence of kanamycin. This procedure was repeated once to obtain a
total of three plating steps on kanamycin-containing medium. The
final N. meningitidis HB-1 mutants (HB-1+kanR and HB-
1+kanR+pfkA) were used to generate stock-cultures.
Rapid sampling. When the chemostat cultures were run, a full-
genome N. meningitidis microarray was not yet available at the NVI.
For this reason we decided to quench the culture broth using a rapid
sampling procedure followed by low-temperature storage to freeze
bacterial metabolism and preserve RNA. The practical rapid sampling
setup of Lange et al. (2001) was adjusted by addition of air filters
(0.2 mm pore-size) at the relevant points to construct a closed system
that was suitable for working with pathogens. In steady state, four
samples of 5 ml were taken in 35 ml 240 uC quenching solution
[60% (w/w) methanol buffered with 10 mM HEPES, pH 7.5 (Lange
et al., 2001)] and stored at 280 uC until further analysis. The
quenched samples were stored for 2 years prior to RNA isolation.
Microarrays. Samples were analysed using a full-genome N.
meningitidis microarray. Based on the genome sequence of N.
meningitidis serogroup B strain MC58 (Tettelin et al., 2000), a set
of 2078 70-mer oligonucleotides was developed at Operon
(Germany), covering 93% of all predicted ORFs. In addition, a
single 70-mer pfkA oligonucleotide sequence from E. coli K-12 was
added to the set. Oligonucleotide pellets were dissolved in 50%
DMSO (v/v, in water) to a concentration of 20 mM and spotted in
triplicate on UltraGAPS II coated slides (Corning), using the
Omnigrid 100 microarray spotter (GeneMachines). During steady
state, duplicate RNA samples were taken from one chemostat for each
bacterial strain. The third RNA sample was taken from the duplicate
chemostats, giving a total of four chemostat cultivations. For each
microarray sample, the quenched bacterial culture samples were used
directly for RNA isolation. The amount of quenched bacterial culture
used for RNA isolation was equal to 1.2 ml per OD590 unit to ensure
that an equal amount of bacteria was used as starting material. The
samples were concentrated by centrifugation (3000 g, 15 min) and
treated with Tris-EDTA buffer containing 0.5 mg lysozyme ml21
(Sigma-Aldrich) for 3 min. Total RNA was extracted with the SV
Total RNA isolation system according to the manufacturer’s protocol
(Promega Benelux). Nucleic acid concentration was adjusted by
precipitation and spectral analysis was used to determine final nucleic
acid concentration and purity. RNA integrity was confirmed with the
Bioanalyser RNA6000 Nano assay (Agilent Technologies), according
to the manufacturers’ protocol. RNA integrity was predicted by
calculation of the RNA integrity number (RIN) (Schroeder et al.,
2006).
Total RNA from three experimental samples per strain was reverse-
transcribed to cDNA and labelled with Cy3 dye using the Chipshot
Indirect Labeling and Clean-Up kit (Promega Benelux) according to
the manufacturer’s protocol, with one deviation: 2 ml random primer
and no oligo-dT primer was used per reaction to reverse transcribe
the RNA. Common reference samples, containing equal amounts of
total RNA from all three experimental samples, were labelled with
Cy5. The labelled and purified cDNA samples were pooled in Cy3/
Cy5 pairs and volumes were adjusted to 25 ml. An equal volume of
hybridization buffer was added, to a final concentration of 25%
formamide, 56 SSC and 0.1% SDS. Samples were applied to the
microarray slides and placed in a hybridization chamber
(GeneMachines) for 16–20 h at 42 uC in the dark. Differential gene
expression levels were calculated through comparison with a common
reference sample, containing equal amounts of RNA from all
experimental samples. The microarrays were scanned with a
ScanArray Express microarray scanner (Perkin Elmer) and median
fluorescence intensities were quantified for each spot using
ArrayVision software (Imaging Research). The expression data were
natural-log-transformed and quantile-normalized, and values of
replicate spots were averaged. These data processing steps were done
with the free statistical software R (WU), using an in-house-
developed script. P values were calculated using one-way ANOVA
statistical analysis. Fold ratio (FR) values were expressed as the
natural log of the normalized signal difference between the two
groups. A P value below 0.05 was used to select differentially
expressed genes. To further select for biologically relevant effects, only
genes that combined both a low P value with and an FR above 2.00
were included in the final results (see Supplementary Material,
transcriptome worksheet).
Phylogenetic profiling. To determine the presence or absence of the
pfkA gene and other genes related to glucose metabolism and glucose
transport, in different species, the STRING database (http://
string.embl.de/; von Mering et al., 2005) was used as a starting point.
The protein sequences of the relevant genes of E. coli were used as an
input. In cases where no or very low homology was found in N.
meningitidis, although functionality has been indicated elsewhere
(http://www.biocyc.org/; http://www.genome.ad.jp/kegg/), the pro-
tein sequences of the relevant genes of N. meningitidis were also used
as input. In order to interpret the results obtained from the
alignments more easily, the STRING scores were converted to a
colour scale based on four colours using an in-house computer
program running in Visual Basic (Microsoft). In this program the
homology scores (bitscores) of the relevant protein sequence of a
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species serve as an input. In the cases where no sequence homology
was found, the colour red was assigned. In the cases where some
homology was found but the bitscore was below the general threshold
value of 60 (http://string.embl.de/), the colour orange was assigned.
The genes that were present are indicated by the colour green and
high homology (high scores) are indicated by a slightly darker green.
The reliability of the colour rescaling was checked by cross-
referencing using BLASTP and two randomly chosen protein sequences,
which confirmed the results obtained.
Metabolic modelling. Methods for solving a metabolic network or
set of linear equations have been discussed extensively elsewhere
(Edwards et al., 1999, 2001; Forster et al., 2002; Vallino &
Stephanopoulos, 1990; van Gulik & Heijnen, 1995). Briefly, first the
genome-scale metabolic model (Baart et al., 2007a) was simplified as
described previously (Baart et al., 2008). Next, an acetaldehyde
exchange reaction was added based on the measurement of
acetaldehyde in the culture supernatant. In addition, for the HB-
1+kanR+pfkA strain, the irreversible PFK reaction was added to the
model (see Supplementary material, model worksheet). For both
cases, the primary measurements were translated to measured
conversion rates using mass balances, and all measurement errors
were translated to errors (i.e. variances) in measured conversion rates
using Monte Carlo simulation (MCS), as described previously (Baart
et al., 2007a).
The redundancy matrix expressing the redundancy relations between
the measured exchange rates was calculated for each individual
dataset and contained two independent equations. Inspection of these
equations indicated a carbon and a nitrogen balance. Both metabolic
models (HB-1+kanR and HB-1+kanR+pfkA) are partly under-
determined. Linear optimization (i.e. linear programming, LP) was
combined with MCS and used to find a single, unique, optimal value
for the objective function maximization of ATP hydrolysis as
described previously (Baart et al., 2008). Since ATP is an intermediate
metabolite that cannot accumulate, maximization of the hydrolysis
reaction automatically means that in the rest of the network ATP
production is maximized. It is noteworthy that this single solution is
not necessarily unique and that there can be more than one flux
distribution that reaches the optimal value of the objective function.
In silico flux balance analysis (FBA). Prior to balancing and LP
(FBA), in silico FBA simulations were done in order to determine the
possible increase in yield as a result of the introduction of pfkA. The
protein, fatty acid and biomass biosynthesis reactions in the in silico
FBA simulations were based on the measured average composition
which had been determined previously (Baart et al., 2008). The
following external metabolites were allowed to freely enter and leave
the system: ammonia, water, phosphate, thiosulfate, sulfate, carbon
dioxide, oxygen and protons. In addition, amino acids, acetate,
hydrogen sulfide, ethanol and extracellular protein were only allowed
to leave the system. Glucose was the sole carbon source that was
allowed to enter the system. The objective function used in in silico
FBA was the maximization of biomass. This objective function was
found to result in biologically meaningful predictions in nutrient-
limited continuous E. coli cultures (Schuetz et al., 2007). In silico FBA
was combined with MCS using previously determined substrate (Yx/s,
ms) and energy parameters (Yx/ATP, mATP) and their corresponding
variances (Baart et al., 2008) as input for optimization at different
chosen growth rates. The complete procedure was as follows. First, a
growth rate was chosen and at this growth rate a thousand values for
the corresponding consumption rate of glucose, the growth-
associated ATP requirement for biomass and the flux through the
non-growth-associated ATP-maintenance reaction (mATP) were
calculated using MCS and stored as temporary dataset. Second, each
set of these simulated values was used as input for in silico FBA and
the flux distribution results were stored in a second temporary matrix.
After completion of the simulations at the chosen growth rate, the
mean value and the corresponding variance of each flux and exchange
rate were calculated. Then the next growth rate was selected and the
above described procedure was done again. After completion of the in
silico FBA calculations for strain HB-1+kanR, the stoichiometric
matrix corresponding to strain HB-1+kanR+pfkA was selected and
the complete procedure was repeated using the same growth rates as
an input. The Monte Carlo approach was used in order to estimate
the errors in the calculated in silico yield values (Yinsilicox=s ) at the
different growth rates in the two strains. The stoichiometric matrices
used in this study were constructed from the set of reactions using a
custom made computer program running in Visual Basic (Microsoft).
Both MCS and FBA were executed in custom-made computer
programs running in Matlab (version 6.5 r13; Mathworks).
RESULTS AND DISCUSSION
In silico FBA
A functional glycolysis in N. meningitidis by inclusion of
PFK theoretically leads to an increase in the biomass yield,
as shown in Fig. 2. The possible increase in biomass yield is
higher when the growth rate is lower, as expected. Since
functional glycolysis only produces one additional ATP
molecule to add to a total of about 20 ATPs in central
metabolism, the effect of PFK when cells grow at a low
growth rate becomes relatively more important, since the
availability of ATP for biomass growth decreases with
decreasing growth rates due to maintenance requirements.
In other words, the more limiting energy becomes for
growth the more important it is to increase the yield of
Fig. 2. Percentage improvement of in silico biomass yield (Yinsilicox=s )
in the pfkA+ strain at various growth rates (m) in comparison with
the HB-1+kanR strain. The grey lines represent the SD of the
predictions (#). Since the substrate and energy parameters (see
Methods) were estimated in the 0.04–0.16 range of growth rates,
the mean line (black) is dashed outside this range.
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ATP on a substrate and thus the more advantageous PFK
becomes.
Phylogenetic profiling
Phylogenetic profiling (see Supplementary Material, phylo-
genetic profiling worksheet) reveals that many genomes of
both c- and d-Proteobacteria, Acidobacteria, Firmicutes,
Bacteroidetes, Actinobacteria, some Cyanobacteria and all
Eukaryota contain a pfkA gene (or a pfkA homologue), while
it is absent in most a-Proteobacteria, b-Proteobacteria and
Chlamydiae genomes, and in Archaea (see Supplementary
Material). Notably, all listed Firmicutes, d-Proteobacteria
and Acidobacteria contain a pfkA homologue. The presence
of pfkA in all listed families, but not in Archaea, indicates
that its origin is ancient. However, its phylogenetic
distribution is patchy and complex. For instance, the
genomes of two species within the listed b-Proteobacteria
(i.e. Rhodoferax ferrireducens and Chromobacterium viola-
ceum) contain a pfkA homologue, while all other species do
not. Observations within all the described families of
Bacteria show similar results. In other words, there always
seem to be one or more species within a family that contains
a pfkA gene, so phylogenetically based discrimination to
reconstruct the evolutionary history of pfkA does not seem
possible. However, the patchy phylogenetic distribution
suggests, as indicated elsewhere (Bapteste et al., 2003), that
pfkA can be lost during the evolution of a species.
Phylogenetic profiling indicates that the genomes of most
anaerobic organisms (e.g. Clostridium species) contain a
pfkA gene. Since little energy is generated from substrate in
anaerobically grown species, the relative gain in ATP yield
increases significantly when the glycolytic pathway is
present. This is in agreement with the obtained in silico
FBA results, since at a low growth rate, an increased yield is
predicted. The absence of a pfkA gene in anaerobic
organisms goes together with the absence of genes related
to the EMP pathway and/or the absence of glucose transport
capabilities. In facultative anaerobic species, the presence or
absence of a pfkA gene is more variable. For instance, the
genomes of Escherichia species, Shigella species, Salmonella
species, Haemophilus species, Mannheimia succiniciprodu-
cens, Staphylococcus species, Corynebacterium species,
Listeria species, Yersinia species and Vibrio species contain
a pfkA homologue, while the genomes of Legionella species,
Chlamydophila species and Chlamydia species do not. In the
genomes of the last three genera, additional genes related to
the EMP pathway are also not present. Similar to facultative
anaerobic species, the distribution of the pfkA gene in
obligate aerobic species is variable; however, most obligate
aerobic species seem to lack pfkA (e.g. Burkholderia,
Neisseria, Helicobacter and Bordetella species). From an
energy point of view, the lack of pfkA in an obligate aerobe
seems obvious, since the contribution of PFK to the energy
supply in an aerobically grown organism is limited in
comparison with the energy generated through oxidative
phosphorylation, which might explain the absence of pfkA in
the N. meningitidis genome. In other words, under aerobic
conditions, the substrate is more important for anabolism
(i.e. supply of intermediates for growth), than for generating
energy. Under anaerobic or microaerobic conditions the
reverse is true; the substrate is more important for energy
generation than for anabolism, and PFK provides an
advantage. Therefore, in the case of a limiting energy supply,
the objective of an organism seems to be to optimize the
yield of energy from a substrate (maximize YATP/s). In
contrast, in the case of sufficient available energy, it seems
that the strategy of organisms is to consume this energy as
fast as possible (maximize rATP) in order to outcompete
other micro-organisms living in the same habitat. However,
there always seems to be a trade-off between high biomass
yield and the high energy dissipation rates necessary for fast
growth, as examined extensively by von Stockar and co-
workers (Liu et al., 2007; von Stockar et al., 2006). Schuetz et
al. (2007) found that under carbon (and energy) limitation
in a chemostat, E. coli aims at maximization of biomass. In
the case of an excess availability of carbon (and energy), the
E. coli metabolism operates in such a way that a minimal
number of biochemical reactions are used to generate the
required ATP. This typical overflow metabolism (e.g.
production of acetate) results in less efficient energy
utilization of the carbon source. Nevertheless, the resulting
suboptimal yields go hand in hand with dissipation of more
energy and thereby enable higher catabolic rates (Schuetz et
al., 2007), which might be a way to outcompete other
organisms living in the same habitat. Furthermore, the
excreted products such as acetate and ethanol may inhibit
the growth of other organisms. This shows that E. coli has
developed a mechanism that compromises between growth
efficiency (i.e. biomass yield) and metabolic rate (i.e. growth
rate), and the environmental conditions (i.e. habitat)
determine which mechanism is preferred. There is more
experimental evidence showing that at carbon substrate
limitation, high-yield pathways are indeed adopted (Brauer
et al., 2005; Postma et al., 1989; Vulic & Kolter, 2001).
In N. meningitidis, glucose uptake proceeds via glucokinase
(NMB1390). In the genomes of Staphylococcus and
Streptococcus, other known inhabitants of the nose and
throat, pfkA is present while glucokinase is absent, and
glucose uptake proceeds via the PEP : carbohydrate phos-
photransferase system (PTS system). PTS-mediated sub-
strate uptake involves the transfer of the phosphoryl group
of the high-energy metabolite PEP to the carbohydrate
through a cascade of phosphotransfer proteins (Deutscher
et al., 2006; Postma et al., 1993). The significantly
decreasing transcription level of pfkA in a PTS-deficient
E. coli mutant (DptsHIcrr) in comparison with the wild-
type (Flores et al., 2005) suggests that there is a correlation
between PFK and PTS. Since a functional EMP pathway
can generate twice as much PEP from glucose than the ED
pathway, the presence of PFK and the PTS system indeed
seems to go hand in hand. To illustrate the possible
correlation between PFK and the PTS system, Fig. 3 shows
Venn diagrams for pfkA, glk (glucokinase, GK) and ptsG
(glucose-specific PTS transporter EIIBGlc) in c- and b-
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Proteobacteria, Firmicutes and Actinobacteria. No ptsG
homologs have been found in e- and d-Proteobacteria,
Acidobacteria, Chlamydiae, Bacteroidetes and Cyanob-
acteria species, whereas pfkA homologues are present in
some of these species (see Supplementary Tables S1–S3).
From the Venn diagrams (Fig. 3) it can be calculated that in
157 of the 210 cases, PFK and EIIBGlc are correlated (75%),
meaning that either they are found together or neither is
present, or, stated differently, in the 156 cases where either
PFK or EIIBGlc is present, they are present together in 103
cases, which indicates that they are correlated. PFK and GK
are correlated in 22% of the cases, and GK and EIIBGlc are
correlated in 40% of the cases. In 38 of the 210 cases shown
in the Venn diagrams (18%), PFK, EIIBGlc and GK are
correlated. When the 312 bacterial species listed in the
phylogenetic profile are taken into consideration, PFK and
EIIBGlc are correlated in 69% of the cases (see
Supplementary Tables S1–S3). Notably, phylogenetic pro-
filing indicates that the EI PTS protein (encoded by ptsI), is
present in 92, 20 and 96% of the Bacteria, Eukaryota and
Archaea, respectively, which clearly indicates more (ancient)
functional roles for the PTS system.
Since the PTS system is typical for anaerobic and
facultative aerobic organisms (Postma et al., 1993), the
lack of a PTS system in N. meningitidis seems obvious.
Although, during infection, pathogenic N. meningitidis
encounters host anatomical sites with low oxygen levels,
which indicates that anaerobic metabolism is required
(Bartolini et al., 2006; Nassif et al., 1999), one can argue
that this requirement is not a main determinant of N.
meningitidis evolution; in particular, natural evolution of
N. meningitidis takes place in the aerobic nasopharyngeal
mucosa. The possibility cannot be ignored that other main
nutrients for growth (for example lactate), which are not
processed via F6P and are present the natural habitat of N.
meningitidis, might also be determinants of pfkA deficiency
in N. meningitidis. In conclusion, for growth on hexose
sugars, whether a micro-organism is strictly anaerobic or
strictly aerobic seems to be the most important factor
determining the presence or absence of PFK, and is
correlated with the presence or absence of a PTS system,
respectively, and thus can also explain the absence of PFK
in N. meningitidis, which is an aerobic bacterium. A second
factor, which can also be important, is growth on
substrates that enter metabolism below the PFK level, such
as lactate.
RNA integrity and comparison of expression profiles
Gene expression profiles were analysed by taking three
RNA samples for each strain (HB-1+kanR and HB-
Fig. 3. Venn diagrams indicating the relation-
ship (numbers in the circles) between PFK
(encoded by pfkA), the glucose-specific PTS
transporter EIIBGlc (encoded by ptsG) and
glucokinase (GK; encoded by glk) in c-
Proteobacteria, b-Proteobacteria, Firmicutes
and Actinobacteria. For example, in 76 of the
listed c-Proteobacteria, pfkA, ptsG and glk
homologues are present in 44, 39 and 51
species, respectively. In 34 species, pfkA and
ptsG homologues are both present, whereas in
27 species, pfkA and ptsG homologues are
both absent (number outside the circles).
Hence, in 61 (27+34) of the 76 cases
(80%), PFK and EIIBGlc are correlated. In 25
species, pfkA and glk homologues are both
present, whereas in six species, pfkA and glk
homologues are both absent. Therefore, in 31
cases (41%), PFK and GK are correlated. In
27 species, glk and ptsG homologues are both
present, whereas in 13 organisms, glk and
ptsG homologues are both absent (correlation
in 53% of the cases). In 24 of the 76 c-
Proteobacteria (number in the centre), all three
homologues are present, whereas homologues
are absent in four cases (4/76), which means
that in 37% of the cases, PFK, EIIBGlc and GK
are correlated.
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1+kanR+pfkA). Steady-state duplicate RNA samples were
taken from one chemostat and one RNA sample from a
second chemostat (chemostat duplicate), giving a total of
six RNA samples for two strains. The RNA integrity
number scores (Schroeder et al., 2006) of the RNA samples
ranged from 9.4 to 9.8, indicating that the RNA was of
good quality and suitable for use in DNA microarray
analysis. This shows that the rapid sampling protocol used
in this study followed by storage of the quenched biomass
at 280 uC prevents RNA degradation for a long period of
time (at least 2 years). Gene expression correlation within
the chemostat duplicates was high and similar to the
correlation between the chemostat duplicates (all R2 values
were between 0.940 and 0.972). Therefore, all RNA samples
from each strain were used as independent replicates
during statistical analysis. The averaged gene expression
differences indicate that the heterologous pfkA gene is
expressed in strain HB-1+kanR+pfkA. Introduction of
the pfkA gene in N. meningitidis induced a change in the
gene expression level of the pfkA gene (FR52.6, P50.013)
and high gene expression changes (FR .3.7, P,0.003) in
the expression of only seven genes. These genes were
upregulated in strain HB-1+kanR+pfkA and include the
pilE gene (NMB0018) and six pilS genes (NMB0020,
NMB0021, NMB0022, NMB0023, NMB0025 and
NMB0026). These virulence genes are phase-variable, i.e.
are subject to reversible on/off switching of the expression
state (Davidsen & Tonjum, 2006). Therefore, it is possible
that the ‘on’ expression state of these genes was selected
during strain construction and that the upregulation of
these genes is not the result of heterologous pfkA
expression. Hence, no large effects related to heterologous
expression of pfkA were observed in the transcriptome.
Physiological and metabolic observations
Successful expression of PFK in N. meningitidis HB-
1+kanR+pfkAwas indicated by measuring the PFK activity
in cell-free extracts using a coupling enzyme assay. In the
HB-1+kanR+pfkA cell lysate, the measured PFK activity
was 440 U l21. If it is assumed that all enzyme was liberated
during the procedure to obtain cell-free extract, this
translates into a specific PFK activity of 0.015 mol
(g dcw)21 h21 [0.353 mmol (mg protein)21 min21].
Notably, this observed PFK activity was significantly lower
(133-fold) than the measured PFK activity level in E. coli
[47 mmol (mg protein)21 min21] grown in batch culture on
LB medium (Ogawa et al., 2007). This may be due to the
strength of the rmpM promoter, the presence of allosteric
inhibitors as explained in the Introduction, or to active
fructose-1,6-bisphosphatase in theN. meningitidis cell extract,
which might interfere with the activity measurement (Uyeda
& Luby, 1974). Interference is unlikely in the E. coli cell
extract, since fructose-1,6-bisphosphatase is not required for
growth on hexoses and pentoses (Fraenkel &Horecker, 1965).
The macromolecular biomass composition was determined
on the two duplicate aerobic glucose-limited chemostat
cultures and is shown in Table 1. In strain HB-
1+kanR+pfkA, the RNA content was significantly higher
and the LPS content lower, whereas no significant changes
were observed for the other components. The cellular
amino acid composition of the two strains did not differ
significantly (Table 2). We observed small differences in
fatty acid composition (Table 3). In particular, the
unsaturated hexadecenoic acid (C16 : 1) content in strain
HB-1+kanR+pfkA was somewhat higher, while the
dodecanoic acid (C12 : 0), hydroxydodecanoic acid
(C12 : 0-3OH) and octadecanoic acid (C18 : 0) content
was somewhat lower. Overall the changes in the biomass
composition were minimal.
The redundancy matrix, expressing the redundancy rela-
tions between the measured exchange rates, was calculated
for each individual dataset and contained a carbon and a
nitrogen balance. The residuals obtained after multiplica-
tion of the redundancy matrix by the measured exchange
rates could be explained on the basis of random
measurement variances with test values that were lower
than the 95% chi-squared critical value of 5.992 (van der
Heijden et al., 1994). In addition, the individual carbon
and nitrogen balances could be closed for all datasets.
Hence, the carbon- and nitrogen-containing exchange rates
were balanced.
The measured (balanced) C-mol yield of biomass on
substrate, Yx/s, in strain HB-1+kanR+pfkA was found to
be 0.45±0.03 C-mol C-mol21, while Yx/s in strain HB-
1+kanR was found to be 0.52±0.03 C-mol C-mol21.
Notably, predictions obtained from in silico FBA, at the
same growth rate of 0.13 h21, indicated a small Yx/s
Table 1. Measured macromolecular composition (%, w/w) of










*The overall phospholipid composition used in the present study was
based on the values provided by Rahman et al. (2000), including 11%
phosphatidate (PA), 71% phosphatidylethanolamine (PE) and 18%
phosphatidylglycerol (PG).
DLPS was quantified based on the measured amount of C12 : 0-3OH
and possesses uncertainty (Baart et al., 2008).
dPeptidoglycan in N. meningitidis was estimated based on E. coli
(Neidhardt & Umbarger, 1996), and the composition was based on
the average of the peptidoglycan structures present in N. meningitidis
(Antignac et al., 2003). For modelling purposes a relative mean
standard deviation of 10% was assumed.
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increase for strain HB-1+kanR+pfkA. This might explain
why the pfkA gene is not obtained by HGT, since it is
initially unfavourable for biomass yield. The lower Yx/s in
strain HB-1+kanR+pfkA means that less carbon is
assimilated in biomass, which was compensated mainly
by an increase in CO2 production (i.e. 0.52±0.06 C-mol
C-mol21 for strain HB-1+kanR+pfkA and 0.44±0.04 C-
mol C-mol21 for strain HB-1+kanR), while the produc-
tion of by-products (i.e. ethanol, acetate, acetahldehyde,
lactate, amino acids and proteins) was low and similar in
the two strains (i.e. 0.03±0.01 C-mol C-mol21 for strain
HB-1+kanR+pfkA and 0.05±0.01 C-mol C-mol21 for
strain HB-1+kanR).
As explained in Methods, a single solution for the
underdetermined parts (see Supplementary Material,
model worksheet) of both metabolic networks was
calculated using maximization of ATP yield (maxATP) as
an objective function. Both the ED pathway and the EMP
pathway are underdetermined, which means that the
calculated fluxes for these parts are determined by the
objective function. Due to the thiosulfate conversion
reaction (reaction 51 in the model), the oxidative
phosphorylation reaction (reaction 71 in the model) is
also underdetermined. However, based on the thiosulfate
concentration in the medium (0.38 mM), we calculate that
the maximum oxygen consumption rate for this reaction is
less than 1% of the measured oxygen consumption rate,
which means that the measured oxygen consumption rate
determines the rate of the oxidative phosphorylation
reaction and therefore ATP production from this source.
It was found that in the HB-1+kanR+pfkA strain, 24% of
the total ATP was formed in the EMP pathway, the citric
acid cycle and the acetate production reaction, whereas in
the HB-1+kanR strain, 16% of the total ATP was formed
in the ED pathway, the citric acid cycle and the acetate
production reaction. In both strains, the remainder of the
ATP was formed by oxidative phosphorylation (see
Supplementary data, flux distributions worksheet). As
expected, using this objective function, the HB-1+kanR
strain processes glucose 6-phosphate solely through the ED
pathway, since the ED pathway can yield slightly more
energy per molecule of glucose consumed than the PP
pathway (Baart et al., 2008). It was found that the ATP
hydrolysis flux (i.e. the flux that was maximized) was twice
as high in the HB-1+kanR+pfkA strain (see
Supplementary data, flux distributions worksheet). Even
if it is assumed that the EMP pathway is not active in the
PFK-positive strain due to a PFK activity that is too low,
and that glucose is metabolized through the ED pathway,
the ATP hydrolysis flux is still 1.6 times higher in the PFK-
positive strain. This means that in the PFK-positive strain
more ATP is produced, which is directly related to the
higher oxygen consumption measured for this strain. The
Table 2. Measured cellular amino acid composition (%, w/w)























Table 3. Measured cellular fatty acid composition (%, w/w) of N. meningitidis strains HB-1+kanR (pfkA”)
and HB-1+kanR+pfkA (pfkA+) (mean±SD)
Component pfkA” pfkA+
Dodecanoic acid (C12 : 0) 7.99±0.33 6.93±0.33
3-Hydroxydodecanoic acid (C12 : 0-3OH) 7.54±0.26 6.83±0.24
3-Hydroxytetradecanoic acid (C14 : 0-3OH)* 3.31±0.27 3.50±0.12
Tetradecanoic acid (C14 : 0) 8.53±0.26 7.72±0.25
Hexadecenoic acid (C16 : 1 trans-9) 20.92±0.83 23.29±0.75
Hexadecenoic acid (C16 : 1 v-7-cis) 0.40±0.02 0.46±0.02
Hexadecanoic acid (C16 : 0) 39.53±1.4 38.98±1.43
Octadecenoic acid (C18 : 1 v-7-cis) 10.52±0.44 11.40±0.72
Octadecanoic acid (C18 : 0) 1.26±0.06 0.89±0.06
*The C14 : 0-3OH quantity was calculated from the corresponding measured C12 : 0-3OH quantity, as explained
previously (Baart et al., 2008).
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expected effect on biomass yield due to the extra ATP
produced is abolished by an ATP-consuming process,
which can be stress, protein turnover or futile cycling in
combination with fructose bisphosphatase, resulting in the
loss of ATP. To compensate for this, more ATP must be
generated from glucose, resulting in more O2 consumption
and CO2 generation, and a decrease in biomass yield. The
biomass composition of both strains is similar, which
indicates that it is unlikely that more ATP is required for
HB-1+kanR+pfkA biomass formation. Notably, the
measured PFK activity in the HB-1+kanR+pfkA strain
is sufficient to explain the additional ATP turnover and the
calculated PFK flux. In the HB-1+kanR+pfkA strain, the
calculated PFK flux is 0.002 mol g21 h21 and the increase
in the ATP hydrolysis reaction upon PFK introduction is
0.008 mol g21 h21 (see Supplementary data, flux distribu-
tions worksheet). If we assume that this additional ATP
hydrolysis is caused by futile cycling through PFK and
phosphatase, then the total PFK flux is 0.01 mol g21 h21,
which is 32% lower than the measured specific PFK
activity (0.015 mol g21 h21) in the HB-1+kanR+pfkA
strain and shows that the calculated flux is feasible. Hence,
futile cycling upon introduction of pfkA in N. meningitidis
seems the most plausible ATP-consuming process.
No significant differences between the maximum growth
rates of the two strains were observed during the batch
phase preceding the chemostat phase (results not shown).
Theoretically, a higher yield would be expected, and due to
the above-mentioned trade off between high biomass yield
and high energy dissipation rates a lower maximum growth
rate would be expected. As a result of futile cycling, ATP is
lost (and energy is dissipated), more CO2 is produced and
a lower yield of biomass on substrate is found. The extra
dissipation of energy may explain why a lower growth rate
was not found, which is thus in line with the theory.
Adaptive evolution to achieve a robust, optimal metabolic
network that enables a higher growth rate (Hua et al.,
2007) or a higher yield might be possible.
Conclusions
The phylogenetic distribution of PFK indicates that it is
lacking in most obligate aerobic organisms. In many
(facultative) anaerobic organisms, PFK is present and goes
hand in hand with the presence of a PTS system. A
competitive advantage under anaerobic conditions seems
to be the most important factor for the presence of PFK. In
the case of limiting energy availability due to the absence of
oxidative phosphorylation, the objective of an organism
seems to be to optimize the yield of energy on substrate
(maximize YATP/s), favouring PFK. In the case when
sufficient energy can be liberated from the substrate by
oxidative phosphorylation, the objective of an organism
seems to be to optimize the rate of energy generation
(maximize rATP) in order to outcompete other micro-
organisms living in the same habitat. Since the natural
evolution of N. meningitidis takes place in the aerobic
nasopharyngeal mucosa, the absence of pfkA in the N.
meningitidis genome can be explained. In silico FBA
predicts an increase in biomass yield upon inclusion of
PFK. However, experimentally, a lower biomass yield is
found in the presence of PFK than in the control strain
without PFK. We hypothesize that this is caused by active
phosphatases, creating futile cycles and the dissipation of
energy. This makes it clear that no initial advantage is
gained when PFK is expressed in N. meningitidis, which
indicates that possible HGT events to obtain the pfkA gene
are unlikely.
ACKNOWLEDGEMENTS
We thank Jeroen Pennings for his help with the microarray analysis
and data processing, Marieke Willemsen, Elly Verhagen and Jan van
den Ijssel for practical assistance, Alex de Haan for HPLC and GC
measurements, Martin Hamzink for NMR measurements, Marcel
Hoefnagel for sharing his knowledge of the determination of
phosphofructokinase activity in cell-free extracts, Jo Maertens for
his work on sequence analysis and Christoph Schoen for sharing his
view on this subject. We also acknowledge the Gonococcal Genome
Sequencing Project, and B. A. Roe, S. P. Lin, L. Song, X. Yuan, S.
Clifton and D. W. Dyer, supported by USPHS/NIH grant #AI38399.
REFERENCES
Antignac, A., Rousselle, J. C., Namane, A., Labigne, A., Taha, M. K. &
Boneca, I. G. (2003). Detailed structural analysis of the peptidoglycan
of the human pathogen Neisseria meningitidis. J Biol Chem 278,
31521–31528.
Baart, G. J., Zomer, B., de Haan, A., van der Pol, L. A., Beuvery, E. C.,
Tramper, J. & Martens, D. E. (2007a).Modeling Neisseria meningitidis
metabolism: from genome to metabolic fluxes. Genome Biol 8, R136.
Baart, G. J. E., de Jong, G., Philippi, M., Riet, K. V. T., van der Pol, L. A.,
Beuvery, E. C., Tramper, J. & Martens, D. E. (2007b). Scale-up for
bulk production of vaccine against meningococcal disease. Vaccine 25,
6399–6408.
Baart, G. J. E., Willemsen, M., Khatami, E., de Haan, A., Zomer, B.,
Beuvery, E. C., Tramper, J. & Martens, D. E. (2008). Modeling
Neisseria meningitidis B metabolism at different specific growth rates.
Biotechnol Bioeng 101, 1022–1035.
Bapteste, E., Moreira, D. & Philippe, H. (2003). Rampant horizontal
gene transfer and phospho-donor change in the evolution of the
phosphofructokinase. Gene 318, 185–191.
Bartolini, E., Frigimelica, E., Giovinazzi, S., Galli, G., Shaik, Y.,
Genco, C., Welsch, J. A., Granoff, D. M., Grandi, G. & Grifantini, R.
(2006). Role of FNR and FNR-regulated, sugar fermentation genes in
Neisseria meningitidis infection. Mol Microbiol 60, 963–972.
Bentley, S. D., Vernikos, G. S., Snyder, L. A., Churcher, C.,
Arrowsmith, C., Chillingworth, T., Cronin, A., Davis, P. H., Holroyd,
N. E. & other authors (2007). Meningococcal genetic variation
mechanisms viewed through comparative analysis of serogroup C
strain FAM18. PLoS Genet 3, e23.
Blangy, D., Buc, H. & Monod, J. (1968). Kinetics of the allosteric
interactions of phosphofructokinase from Escherichia coli. J Mol Biol
31, 13–35.
Bos, M. P. & Tommassen, J. (2005). Viability of a capsule- and
lipopolysaccharide-deficient mutant of Neisseria meningitidis. Infect
Immun 73, 6194–6197.
G. J. E. Baart and others
540 Microbiology 156
Brauer, M. J., Saldanha, A. J., Dolinski, K. & Botstein, D. (2005).
Homeostatic adjustment and metabolic remodeling in glucose-
limited yeast cultures. Mol Biol Cell 16, 2503–2517.
Davidsen, T. & Tonjum, T. (2006). Meningococcal genome dynamics.
Nat Rev Microbiol 4, 11–22.
Deutscher, J., Francke, C. & Postma, P. W. (2006). How
phosphotransferase system-related protein phosphorylation regulates
carbohydrate metabolism in bacteria. Microbiol Mol Biol Rev 70, 939–
1031.
Dorresteijn, R. C., de Gooijer, C. D., Tramper, J. & Beuvery, E. C.
(1994). A method for simultaneous determination of solubility and
transfer coefficient of oxygen in aqueous media using off-gas mass
spectrometry. Biotechnol Bioeng 43, 149–154.
Edwards, J. S., Ramakrishna, R., Schilling, C. H. & Palsson, B. O.
(1999).Metabolic flux balance analysis. InMetabolic Engineering, pp. 13–
57. Edited by S. Y. Lee & E. T. Papoutsakis. New York: Marcel Dekker.
Edwards, J. S., Ibarra, R. U. & Palsson, B. O. (2001). In silico
predictions of Escherichia coli metabolic capabilities are consistent
with experimental data. Nat Biotechnol 19, 125–130.
Elkins, C., Thomas, C. E., Seifert, H. S. & Sparling, P. F. (1991).
Species-specific uptake of DNA by gonococci is mediated by a 10-
base-pair sequence. J Bacteriol 173, 3911–3913.
Exley, R. M., Shaw, J., Mowe, E., Sun, Y. H., West, N. P., Williamson, M.,
Botto, M., Smith, H. & Tang, C. M. (2005). Available carbon source
influences the resistance of Neisseria meningitidis against complement.
J Exp Med 201, 1637–1645.
Flores, N., Flores, S., Escalante, A., de Anda, R., Leal, L., Malpica, R.,
Georgellis, D., Gosset, G. & Bolivar, F. (2005). Adaptation for fast
growth on glucose by differential expression of central carbon
metabolism and gal regulon genes in an Escherichia coli strain lacking
the phosphoenolpyruvate : carbohydrate phosphotransferase system.
Metab Eng 7, 70–87.
Fordyce, A. M., Moore, C. H. & Pritchard, G. G. (1982).
Phosphofructokinase from Streptococcus lactis. Methods Enzymol 90,
77–82.
Forster, J., Gombert, A. K. & Nielsen, J. (2002). A functional genomics
approach using metabolomics and in silico pathway analysis.
Biotechnol Bioeng 79, 703–712.
Fraenkel, D. G. (1996). Glycolysis. In Escherichia coli and Salmonella
typhimurium: Cellular and Molecular Biology, pp. 189–198. Edited
by F. C. Neidhardt, R. Curtiss, J. L. Ingraham, K. Brooks Low, B.
Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter & H. E.
Umbarger. Washington DC: American Society for Microbiology.
Fraenkel, D. G. & Horecker, B. L. (1965). Fructose-1,6-diphosphatase
and acid hexose phosphatase of Escherichia coli. J Bacteriol 90, 837–
842.
Girard, M. P., Preziosi, M. P., Aguado, M. T. & Kieny, M. P. (2006).
A review of vaccine research and development: meningococcal
disease. Vaccine 24, 4692–4700.
Guixe, V. & Babul, J. (1985). Effect of ATP on phosphofructokinase-2
from Escherichia coli. A mutant enzyme altered in the allosteric site for
MgATP. J Biol Chem 260, 11001–11005.
Holten, E. (1974). 6-Phosphogluconate dehydrogenase and enzymes
of the Entner–Doudoroff pathway in Neisseria. Acta Pathol Microbiol
Scand B Microbiol Immunol 82, 207–213.
Holten, E. (1975). Radiorespirometric studies in genus Neisseria. I.
The catabolism of glucose. Acta Pathol Microbiol Scand [B] 83, 353–
366.
Hua, Q., Joyce, A. R., Palsson, B. O. & Fong, S. S. (2007). Metabolic
characterization of Escherichia coli strains adapted to growth on
lactate. Appl Environ Microbiol 73, 4639–4647.
Ito, S., Fushinobu, S., Yoshioka, I., Koga, S., Matsuzawa, H. &
Wakagi, T. (2001). Structural basis for the ADP-specificity of a novel
glucokinase from a hyperthermophilic archaeon. Structure 9, 205–
214.
Jyssum, K. (1962a). Dissimilation of C14 labelled glucose by Neisseria
meningitidis 2. The incorporation of 1-C14 and 6-C14 into pyruvate.
Acta Pathol Microbiol Immunol Scand [B] 55, 335–341.
Jyssum, K. (1962b). Dissimilation of C14 labelled glucose by Neisseria
meningitidis 1. The formation of CO2 and acetate from glucose
carbon. Acta Pathol Microbiol Immunol Scand [B] 55, 319–324.
Jyssum, K. (1962c). Dissimilation of C14 labelled glucose by Neisseria
meningitidis 2. The incorporation of 1-C14 and 6-C14 into cellular
components in short time experiments. Acta Pathol Microbiol
Immunol Scand [B] 55, 325–334.
Jyssum, K., Borchgrevink, B. & Jyssum, S. (1961). Glucose
catabolism in Neisseria meningitidis. 1. Glucose oxidation and
intermediate reactions of the Embden–Meyerhof pathway. Acta
Pathol Microbiol Scand 53, 71–83.
Kroll, J. S., Wilks, K. E., Farrant, J. L. & Langford, P. R. (1998). Natural
genetic exchange between Haemophilus and Neisseria: intergeneric
transfer of chromosomal genes between major human pathogens.
Proc Natl Acad Sci U S A 95, 12381–12385.
Lange, H. C. & Heijnen, J. J. (2001). Statistical reconciliation of the
elemental and molecular biomass composition of Saccharomyces
cerevisiae. Biotechnol Bioeng 75, 334–344.
Lange, H. C., Eman, M., van Zuijlen, G., Visser, D., van Dam, J. C.,
Frank, J., de Mattos, M. J. & Heijnen, J. J. (2001). Improved rapid
sampling for in vivo kinetics of intracellular metabolites in
Saccharomyces cerevisiae. Biotechnol Bioeng 75, 406–415.
Liu, J.-S., Vojinovic, V., Patino, R., Maskow, T. & von Stockar, U.
(2007). A comparison of various Gibbs energy dissipation correlations
for predicting microbial growth yields. Thermochim Acta 458, 38–46.
Muller, M., Lee, J. A., Gordon, P., Gaasterland, T. & Sensen, C. W.
(2001). Presence of prokaryotic and eukaryotic species in all
subgroups of the PPi-dependent group II phosphofructokinase
protein family. J Bacteriol 183, 6714–6716.
Nassif, X., Pujol, C., Morand, P. & Eugene, E. (1999). Interactions of
pathogenic Neisseria with host cells. Is it possible to assemble the
puzzle? Mol Microbiol 32, 1124–1132.
Neidhardt, F. C. & Umbarger, H. E. (1996). Chemical composition of
Escherichia coli. In Escherichia coli and Salmonella typhimurium:
Cellular and Molecular Biology, pp. 13–16. Edited by F. C. Neidhardt,
R. Curtiss, J. L. Ingraham, K. Brooks Low, B. Magasanik, W. S.
Reznikoff, M. Riley, M. Schaechter & H. E. Umbarger. Washington
DC: American Society for Microbiology.
Ogawa, T., Mori, H., Tomita, M. & Yoshino, M. (2007). Inhibitory
effect of phosphoenolpyruvate on glycolytic enzymes in Escherichia
coli. Res Microbiol 158, 159–163.
Omelchenko, M. V., Makarova, K. S., Wolf, Y. I., Rogozin, I. B. &
Koonin, E. V. (2003). Evolution of mosaic operons by horizontal gene
transfer and gene displacement in situ. Genome Biol 4, R55.
Parkhill, J., Achtman, M., James, K. D., Bentley, S. D., Churcher, C.,
Klee, S. R., Morelli, G., Basham, D., Brown, D. & other authors
(2000). Complete DNA sequence of a serogroup A strain of Neisseria
meningitidis Z2491. Nature 404, 502–506.
Peng, J., Yang, L., Yang, F., Yang, J., Yan, Y., Nie, H., Zhang, X., Xiong, Z.,
Jiang, Y. & other authors (2008). Characterization of ST-4821 complex,
a unique Neisseria meningitidis clone. Genomics 91, 78–87.
Postma, E., Verduyn, C., Scheffers, W. A. & Van Dijken, J. P. (1989).
Enzymic analysis of the Crabtree effect in glucose-limited chemostat
cultures of Saccharomyces cerevisiae. Appl Environ Microbiol 55, 468–
477.
Expression of PFK in Neisseria meningitidis
http://mic.sgmjournals.org 541
Postma, P. W., Lengeler, J. W. & Jacobson, G. R. (1993).
Phosphoenolpyruvate : carbohydrate phosphotransferase systems of
bacteria. Microbiol Rev 57, 543–594.
Rahman, M. M., Kolli, V. S., Kahler, C. M., Shih, G., Stephens, D. S. &
Carlson, R. W. (2000). The membrane phospholipids of Neisseria
meningitidis and Neisseria gonorrhoeae as characterized by fast atom
bombardment mass spectrometry. Microbiology 146, 1901–1911.
Rosenstein, N. E., Perkins, B. A., Stephens, D. S., Popovic, T. &
Hughes, J. M. (2001). Meningococcal disease. N Engl J Med 344,
1378–1388.
Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Molecular Cloning:
a Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring
Harbor Laboratory.
Schroeder, A., Mueller, O., Stocker, S., Salowsky, R., Leiber, M.,
Gassmann, M., Lightfoot, S., Menzel, W., Granzow, M. & Ragg, T.
(2006). The RIN: an RNA integrity number for assigning integrity
values to RNA measurements. BMC Mol Biol 7, 3.
Schuetz, R., Kuepfer, L. & Sauer, U. (2007). Systematic evaluation of
objective functions for predicting intracellular fluxes in Escherichia
coli. Mol Syst Biol 3, 119.
Seifert, H. S., Ajioka, R. S., Marchal, C., Sparling, P. F. & So, M.
(1988). DNA transformation leads to pilin antigenic variation in
Neisseria gonorrhoeae. Nature 336, 392–395.
Siebers, B., Klenk, H. P. & Hensel, R. (1998). PPi-dependent
phosphofructokinase from Thermoproteus tenax, an archaeal des-
cendant of an ancient line in phosphofructokinase evolution.
J Bacteriol 180, 2137–2143.
Spratt, B. G., Bowler, L. D., Zhang, Q. Y., Zhou, J. & Smith, J. M.
(1992). Role of interspecies transfer of chromosomal genes in the
evolution of penicillin resistance in pathogenic and commensal
Neisseria species. J Mol Evol 34, 115–125.
Stephens, D. S., Hoffman, L. H. & McGee, Z. A. (1983). Interaction of
Neisseria meningitidiswith human nasopharyngeal mucosa: attachment
and entry into columnar epithelial cells. J Infect Dis 148, 369–376.
Tettelin, H., Saunders, N. J., Heidelberg, J., Jeffries, A. C., Nelson,
K. E., Eisen, J. A., Ketchum, K. A., Hood, D. W., Peden, J. F. & other
authors (2000). Complete genome sequence of Neisseria meningitidis
serogroup B strain MC58. Science 287, 1809–1815.
Trotter, C. L. & Ramsay, M. E. (2007). Vaccination against
meningococcal disease in Europe: review and recommendations for
the use of conjugate vaccines. FEMS Microbiol Rev 31, 101–107.
Uyeda, K. & Luby, L. J. (1974). Studies on the effect of fructose
diphosphatase on phosphofructokinase. J Biol Chem 249, 4562–4570.
Vallino, J. J. & Stephanopoulos, G. (1990). Flux determination in
cellular bioreaction networks: applications to lysine fermentations. In
Frontiers in Bioprocessing, pp. 205–219. Edited by S. K. Sikdar, M. Bier
& P. Todd. Boca Raton, FL: CRC Press.
van der Heijden, R. T. J. M., Romein, B., Heijnen, J. J., Hellinga, C. &
Luyben, K. C. A. M. (1994). Linear constraint relations in biochemical
reaction systems: II. Diagnosis and estimation of gross errors.
Biotechnol Bioeng 43, 11–20.
van der Ley, P. & van Alphen, L. (2001). Construction of porA
mutants. In Meningococcal Vaccines, pp. 145–154. Totowa, NJ:
Humana Press.
van der Ley, P., van der Biezen, J., Hohenstein, P., Peeters, C. &
Poolman, J. T. (1993). Use of transformation to construct antigenic
hybrids of the class 1 outer membrane protein in Neisseria
meningitidis. Infect Immun 61, 4217–4224.
van der Ley, P., van der Biezen, J. & Poolman, J. T. (1995).
Construction of Neisseria meningitidis strains carrying multiple
chromosomal copies of the porA gene for use in the production of
a multivalent outer membrane vesicle vaccine. Vaccine 13, 401–407.
van Gulik, W. M. & Heijnen, J. J. (1995). A metabolic network
stoichiometry analysis of microbial growth and product formation.
Biotechnol Bioeng 48, 681–698.
Verhees, C. H., Tuininga, J. E., Kengen, S. W., Stams, A. J., van der
Oost, J. & de Vos, W. M. (2001). ADP-dependent phosphofructoki-
nases in mesophilic and thermophilic methanogenic archaea.
J Bacteriol 183, 7145–7153.
von Mering, C., Jensen, L. J., Snel, B., Hooper, S. D., Krupp, M.,
Foglierini, M., Jouffre, N., Huynen, M. A. & Bork, P. (2005). STRING:
known and predicted protein–protein associations, integrated and
transferred across organisms. Nucleic Acids Res 33, D433–D437.
von Stockar, U., Maskow, T., Liu, J., Marison, I. W. & Patino, R. (2006).
Thermodynamics of microbial growth and metabolism: an analysis of
the current situation. J Biotechnol 121, 517–533.
Vulic, M. & Kolter, R. (2001). Evolutionary cheating in Escherichia coli
stationary phase cultures. Genetics 158, 519–526.
Zhou, J. & Spratt, B. G. (1992). Sequence diversity within the argF, fbp
and recA genes of natural isolates of Neisseria meningitidis:
interspecies recombination within the argF gene. Mol Microbiol 6,
2135–2146.
Zimmer, S. M. & Stephens, D. S. (2006). Serogroup B meningococcal
vaccines. Curr Opin Investig Drugs 7, 733–739.
Edited by: J. Moir
G. J. E. Baart and others
542 Microbiology 156
